Research workbench
Structure of spastin AAA domain in complex with a quinazoline-based inhibitor
Analyse Structure of spastin AAA domain in complex with a quinazoline-based inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 6NYV
- Type
- protein
- Length
- 283 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 2.425
- Source
- Drosophila melanogaster
- Molecule
- Spastin
- EC
- 5.6.1.1
- UniProt
- Q8I0P1
- Ligands
- LBD, SO4
- Pockets
- 3 · best druggability 0.76
Structure
x-ray diffraction · resolution 2.425 · 1 distinct chain · 57% helix, 10% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| B | Spastin (EC 5.6.1.1) | protein | 283 | 57% helix, 10% strand | Q8I0P1 |
Ligands and binding sites
- LBD · N-(3-tert-butyl-1H-pyrazol-5-yl)-2-[(2R)-2-methylpiperazin-1-yl]quinazolin-4-amine · ligand · chains B
- SO4 · Sulfate ion · ion · chains B
- MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 79 | 0.76 | 0.98 | 21 | empty |
| 2 | 185 | 0.51 | 0.77 | 28 | LBD |
| 3 | 106 | 0.50 | 0.81 | 20 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8I0P1
- Elsewhere: RCSB PDB 6NYV · PDBe 6NYV · UniProt Q8I0P1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.